Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|March 23, 2020
The Cost-effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United StatesGabriel Tremblay, Mike Dolph, Anuja Nidumolu Roy, et al.
Current Medical Research and Opinion|November 6, 2010
Chronic gout: epidemiology, disease progression, treatment and disease burdenRichard A Brook, Anna Forsythe, James E Smeeding, et al.
Cancer Management and Research|June 5, 2018
Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2- advanced breast cancerGabriel Tremblay, David Chandiwana, Mike Dolph, et al.
Sarcoma|May 18, 2017
Evaluation of Quality of Life at Progression in Patients with Soft Tissue SarcomaStacie Hudgens, Anna Forsythe, Ilias Kontoudis, et al.
Breast Cancer (Dove Medical Press)|May 17, 2018
Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2- metastatic breast cancerAnna Forsythe, David Chandiwana, Janina Barth, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 26, 2019
Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature reviewAnna Forsythe, Christina S Kwon, Timothy Bell, et al.
JAMA Pediatrics|March 7, 2022
Humanistic and Economic Burden of Conversion Therapy Among LGBTQ Youths in the United StatesAnna Forsythe, Casey Pick, Gabriel Tremblay, et al.
Pageof 5